Help! Please Register

  Education &
  Tools

  Introduction
  Abbreviations
  Links
  CME
  Conference
   Highlights
  Bibliography
  Glossary
  Good Books
  Events Calendar


  Mycoses

  Introduction
  Human
  Veterinary
  Environmental
   Industrial
  Agricultural
  MSG


  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank


  Drugs

  Introduction
  Medical
  Veterinary
  Environmental
   Industrial
  Agricultural


  Laboratory

  Introduction
  Susceptibility
  MIC Database
  Procedures
  Histopathology


  About Us

  Introduction
  Our Mission
  Editorial Board
  Editorial Staff
  Supporters
  Contributors
  Legal Stuff
  Privacy Policy
  Kudos


  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank



This page updated:
1/27/2007 9:23:00 AM


DoctorFungus - All Rights Reserved © 2007 Copyright
& Privacy Policy


Site built and designed for doctorfungus by Webillustrated



You are here: Education & Tools >
Astellas Pharma Inc.

conference highlightsConference Highlights

Focus on Fungal Infections 14


Animal Models
  1. COMBINATION ANTIFUNGAL THERAPY WITH MICAFUNGIN (MICA) AND AMPHOTERICIN B DESOXYCHOLATE (AMB-D) PROLONGS SURVIVAL IN THE P47PHOX-DEFICIENT MOUSE MODEL OF CHRONIC GRANULOMATOUS DISEASE (CGD) WITH EXPERIMENTAL PULMONARY ASPERGILLOSIS
    Dennis C1, Failing C1, Greco WR1, Slocum H1, Bernacki R1, Pera P1, Lewis R2, Holland SM3, Walsh TJ3, Segal BH1
    1Roswell Park Cancer Institute, Buffalo, USA
    2MD Anderson Cancer Center, Houston, USA
    3National Institutes of Health, Bethesda, USA


top of page    




View other categories
Antifungal Agents | Antifungal Combinations | Antifungal Susceptibility | Basic Mycology
Case Reports | Clinical Mycology | Animal Models | Diagnostics | View All





  Home | Image Bank | Lecture Bank | Knowledgebase | Site Map | Contact Us |
The Fungi | Mycoses | Drugs |
Laboratory | Education & Tools | About Us

  bttm_banner_indv2_02[1].gif